菌株编号 | API 20E | VITEK 2 | VITEK MS | ||||||
鉴定结果 | ID值(%) | t值 | 鉴定结果 | 可信度(%) | 鉴定结果 | 可信度(%) | |||
20-23RT | 腐败施万菌 | 99.70 | 0.90 | 腐败施万菌 | 99.00 | 腐败施万菌 | 99.90 | ||
ATCC 51192T | 腐败施万菌 | 99.70 | 0.90 | 海藻施万菌 | 99.00 | 海藻施万菌 | 99.90 | ||
DW01 T | 腐败施万菌 | 99.70 | 0.90 | 腐败施万菌 | 99.00 | 海藻施万菌 | 99.90 | ||
MAS2723 | 腐败施万菌 | 99.00 | 0.65 | 腐败施万菌 | 99.00 | 海藻施万菌 | 99.90 | ||
LC2016-5 | 腐败施万菌 | 99.00 | 0.90 | 腐败施万菌 | 99.00 | 腐败施万菌 | 99.90 | ||
2014LZ6-2 | 腐败施万菌 | 99.90 | 0.72 | 腐败施万菌 | 99.00 | 腐败施万菌 | 99.90 | ||
2014LZ7-8 | 腐败施万菌 | 99.90 | 0.72 | 腐败施万菌 | 99.00 | 腐败施万菌 | 99.90 | ||
LC2016-1 | 腐败施万菌 | 99.00 | 0.82 | 海藻施万菌 | 99.00 | 海藻施万菌 | 99.90 |

Citation: Shengnan Liang, Xiangkun Jiang, Yinju Du, Pu Zhou, Li Liu, Lihong Cheng and Duochun Wang. Isolation of two rare Shewanella spp. from specimens of patients in Liaocheng[J]. Disease Surveillance. DOI: 10.3784/j.issn.1003-9961.2019.09.010

2016年山东省聊城市临床病例中2种罕见施万菌的鉴定
English
Isolation of two rare Shewanella spp. from specimens of patients in Liaocheng in 2016
-
Key words:
- Shewanella haliotis /
- Shewanella upenei /
- Infection /
- Isolation /
- Identification
-
-
[1]
Pagani L, Lang A, Vedovelli C, et al. Soft tissue infection and bacteremia caused by Shewanella putrefaciens[J]. J Clin Microbiol, 2003,41(5):2240–2241. DOI:10.1128/JCM.41.5.2240−2241.2003.
-
[2]
Chen YS, Liu YC, Yen MY, et al. Skin and soft-tissue manifestations of Shewanella putrefaciens infection[J]. Clin Infect Dis, 1997,25(2):225–229. DOI:10.1086/514537.
-
[3]
Poovorawan K, Chatsuwan T, Lakananurak N, et al. Shewanella haliotis associated with severe soft tissue infection, Thailand, 2012[J]. Emerg Infect Dis, 2013,19(6):1019–1021. DOI:10.3201/eid1906.121607.
-
[4]
Zong ZY. Nosocomial peripancreatic infection associated with Shewanella xiamenensis[J]. J Med Microbiol, 2011,60(9):1387–1390. DOI:10.1099/jmm.0.031625-0.
-
[5]
汪永禄, 王多春, 詹圣伟, 等. 从食物中毒患者标本中分离鉴定海藻和腐败施万菌[J]. 中华流行病学杂志,2009,30(8):836–840. DOI:10.3760/cma.j.issn.0254−6450.2009.08.018.
Wang YL, Wang DC, Zhan SW, et al. Isolation and characterization of Shewanella spp. from patients of food poisoning[J]. Chin J Epidemiol, 2009,30(8):836–840. DOI:10.3760/cma.j.issn.0254−6450.2009.08.018. -
[6]
Wang DC, Wang YL, Huang HN, et al. Identification of tetrodotoxin-producing Shewanella spp. from feces of food poisoning patients and food samples[J]. Gut Pathog, 2013,5:15. DOI:10.1186/1757−4749−5−15.
-
[7]
Holt HM, Søgaard P, Gahrn-Hansen B. Ear infections with Shewanella alga: a bacteriologic, clinical and epidemiologic study of 67 cases[J]. Clin Microbiol Infect, 1997,3:329–334. DOI:10.1111/j.1469−0691.1997.tb00622.x.
-
[8]
Dhawan B, Chaudhry R, Mishra BM, et al. Isolation of Shewanella putrefaciens from a rheumatic heart disease patient with infective endocarditis[J]. J Clin Microbiol, 1998,36(8):2394.
-
[9]
Lane DJ. 16S/23S rRNA sequencing[M]//Stackebrandt E, Goodfellow M. Nucleic acid techniques in bacterial systematics. New York: Wiley, 1991: 115-175.
-
[10]
Fang YJ, Wang YL, Liu ZD, et al. Multilocus sequence analysis, a rapid and accurate tool for taxonomic classification, evolutionary relationship determination, and population biology studies of the genus Shewanella[J]. Appl Environ Microbiol, 2019,85(11):e03126–18. DOI:10.1128/AEM.03126−18.
-
[11]
Clinical and Laboratory Standards Institute(CLSI). Performance standards forantimicrobial susceptibility testing: Twenty-fourth informational supple-ment, 2014, M100-S24[S]. Wayne, PA, USA: CLSI, 2014.
-
[12]
Janda JM, Abbott SL. The genus Shewanella: from the briny depths below to human pathogen[J]. Crit Rev Microbiol, 2014,40(4):293–312. DOI:10.3109/1040841X.2012.726209.
-
[13]
Holt HM, Gahrn-Hansen B, Bruun B. Shewanella algae and Shewanella putrefaciens: clinical and microbiological characteristics[J]. Clin Microbiol Infect, 2005,11(5):347–352. DOI:10.1111/j.1469−0691.2005.01108.x.
-
[1]
-
表 1 微生物鉴定系统结果
Table 1. Result of microbiological identification system
表 2 药敏试验结果
Table 2. Result of antibiotic susceptibility test
抗生素 菌株编号 20-23RT ATCC 51192T DW01T MAS2723 LC2016-5 2014LZ6-2 2014LZ7-8 LC2016-1 氨苄西林 4(S) 16(I) 8(S) ≤2(S) 64(R) 4(S) ≤2(S) 4(S) 头孢他啶 ≤1(S) 2(S) ≤1(S) ≤1(S) ≤1(S) ≤1(S) ≤1(S) ≤1(S) 氨苄西林/舒巴坦 4/2(S) 64/32(R) 32/16(R) ≤2/1(S) 16/8(I) ≤2/1(S) ≤2/1(S) ≤2/1(S) 亚胺培南 1(S) 1(S) 1(S) ≤0.25(S) 1(S) 0.5(S) ≤0.25(S) 0.5(S) 四环素 ≤1(S) 4(S) ≤1(S) ≤1(S) ≤1(S) ≤1(S) ≤1(S) ≤1(S) 萘啶酸 ≤2(S) ≤2(S) ≤2(S) ≤2(S) >64(R) ≤2(S) ≤2(S) >64(R) 红霉素 >16(R) 1(S) ≤0.5(S) ≤0.5(S) ≤0.5(S) ≤0.5(S) ≤0.5(S) ≤0.5(S) 头孢西丁 64(R) 64(R) 32(R) ≤2(S) 4(S) ≤2(S) ≤2(S) ≤2(S) 氯霉素 ≤2(S) 4(S) ≤2(S) ≤2(S) ≤2(S) ≤2(S) ≤2(S) 32(R) 头孢噻肟 ≤0.25(S) 2(I) ≤0.25(I) ≤0.25(S) ≤0.25(S) ≤0.25(S) ≤0.25(S) ≤0.25(S) 头孢唑林 >16(R) >16(R) >16(R) 8(R) >16(R) 16(R) 16(R) 2(S) 庆大霉素 ≤1(S) ≤1(S) ≤1(S) ≤1(S) ≤1(S) ≤1(S) ≤1(S) ≤1(S) 复方磺胺 ≤0.25/0.475(S) ≤0.25/0.475(S) ≤0.25/0.475(S) ≤0.25/0.475(S) ≤0.25/0.475(S) ≤0.25/0.475(S) ≤0.25/0.475(S) >8/152(R) 阿奇霉素 >64(S) >64(S) >64(S) >64(S) >64(S) >64(S) >64(S) >64(S) 环丙沙星 0.125(I) 0.25(I) 0.25(I) ≤0.03(S) 4(R) 0.125(I) ≤0.03(S) 8(R) 注:表内数据为最低抑菌浓度(μg/ml);R. 耐药;I. 中等;S. 敏感 -